Medical Oncology in Ann Arbor, MI
21 verified medical oncology doctors in Ann Arbor.
Medical oncologists diagnose and treat cancer, coordinating chemotherapy and other systemic cancer therapies.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. David Loesch, MD
Medical Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Ulka Vaishampayan, MD
Medical Oncology
CMS Open Payments· $2,542,423 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$2,542,423
Total received
180
Transactions
15
Paying companies
Top paying companies
Among the 4,060 medical oncology doctors we've analyzed, about 60% received any industry payment (median $4,500 among those who did). This doctor's total is higher than 99% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US medical oncology doctors.
Payments to Ulka Vaishampayan do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Ronald Buckanovich, MD
Medical Oncology
CMS Open Payments· $1,013 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,013
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 4,060 medical oncology doctors we've analyzed, about 60% received any industry payment (median $4,500 among those who did). This doctor's total ranks around the 61th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US medical oncology doctors.
Payments to Ronald Buckanovich do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Joshi Alumkal, MD
Medical Oncology
CMS Open Payments· $191,209 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$191,209
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 4,060 medical oncology doctors we've analyzed, about 60% received any industry payment (median $4,500 among those who did). This doctor's total ranks around the 87th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US medical oncology doctors.
Payments to Joshi Alumkal do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Imad Shureiqi, MD
Medical Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Bruce Redman, DO
Medical Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Scott Schuetze, MD
Medical Oncology
CMS Open Payments· $177,139 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$177,139
Total received
5
Transactions
4
Paying companies
Top paying companies
Among the 4,060 medical oncology doctors we've analyzed, about 60% received any industry payment (median $4,500 among those who did). This doctor's total ranks around the 87th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US medical oncology doctors.
Payments to Scott Schuetze do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Mark Zalupski, MD
Medical Oncology
CMS Open Payments· $51,917 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$51,917
Total received
19
Transactions
2
Paying companies
Top paying companies
Among the 4,060 medical oncology doctors we've analyzed, about 60% received any industry payment (median $4,500 among those who did). This doctor's total ranks around the 80th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US medical oncology doctors.
Payments to Mark Zalupski do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Gregory Kalemkerian, MD
Medical Oncology
CMS Open Payments· $106,682 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$106,682
Total received
15
Transactions
4
Paying companies
Top paying companies
Among the 4,060 medical oncology doctors we've analyzed, about 60% received any industry payment (median $4,500 among those who did). This doctor's total ranks around the 84th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US medical oncology doctors.
Payments to Gregory Kalemkerian do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Sami Malek, MD
Medical Oncology
CMS Open Payments· $8,305 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$8,305
Total received
3
Transactions
3
Paying companies
Top paying companies
Among the 4,060 medical oncology doctors we've analyzed, about 60% received any industry payment (median $4,500 among those who did). This doctor's total ranks around the 72th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US medical oncology doctors.
Payments to Sami Malek do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Monika Burness, MD
Medical Oncology
CMS Open Payments· $74,741 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$74,741
Total received
19
Transactions
3
Paying companies
Top paying companies
Among the 4,060 medical oncology doctors we've analyzed, about 60% received any industry payment (median $4,500 among those who did). This doctor's total ranks around the 82th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US medical oncology doctors.
Payments to Monika Burness do not imply any wrongdoing. Many are meals, education, or research support.
Dr. David Wang, MD
Medical Oncology
CMS Open Payments· $24,290 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$24,290
Total received
3
Transactions
3
Paying companies
Top paying companies
Among the 4,060 medical oncology doctors we've analyzed, about 60% received any industry payment (median $4,500 among those who did). This doctor's total ranks around the 76th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US medical oncology doctors.
Payments to David Wang do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Leslie Fecher, MD
Medical Oncology
CMS Open Payments· $81,661 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$81,661
Total received
3
Transactions
1
Paying companies
Top paying companies
Among the 4,060 medical oncology doctors we've analyzed, about 60% received any industry payment (median $4,500 among those who did). This doctor's total ranks around the 83th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US medical oncology doctors.
Payments to Leslie Fecher do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Megan Caram, MD
Medical Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Mary Riwes, DO
Medical Oncology
CMS Open Payments· $238.18 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$238.18
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 4,060 medical oncology doctors we've analyzed, about 60% received any industry payment (median $4,500 among those who did). This doctor's total ranks around the 53th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US medical oncology doctors.
Payments to Mary Riwes do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Erin Cobain, MD
Medical Oncology
CMS Open Payments· $39,246 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$39,246
Total received
14
Transactions
4
Paying companies
Top paying companies
Among the 4,060 medical oncology doctors we've analyzed, about 60% received any industry payment (median $4,500 among those who did). This doctor's total ranks around the 78th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US medical oncology doctors.
Payments to Erin Cobain do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Lan Coffman, MD
Medical Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Angel Qin, MD
Medical Oncology
CMS Open Payments· $290,114 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$290,114
Total received
23
Transactions
6
Paying companies
Top paying companies
Among the 4,060 medical oncology doctors we've analyzed, about 60% received any industry payment (median $4,500 among those who did). This doctor's total is higher than 90% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US medical oncology doctors.
Payments to Angel Qin do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Phoebe Tsao, MD
Medical Oncology
CMS Open Payments· $309,948 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$309,948
Total received
298
Transactions
1
Paying companies
Top paying companies
Among the 4,060 medical oncology doctors we've analyzed, about 60% received any industry payment (median $4,500 among those who did). This doctor's total is higher than 91% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US medical oncology doctors.
Payments to Phoebe Tsao do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Arathi Mohan, MD
Medical Oncology
CMS Open Payments· $95.94 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$95.94
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 4,060 medical oncology doctors we've analyzed, about 60% received any industry payment (median $4,500 among those who did). This doctor's total is on the lower end — around the 47th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US medical oncology doctors.
Payments to Arathi Mohan do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Erin Kropp, MD
Medical Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.